Clinical Trials · NCT01117350
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Sanofi
- Enrollment
- 978
- Start date
- Jul 2010
- Locations
- 136 sites, 17 countries
- Primary endpoint
- Percentage of Patients Whose Glycosylated Haemoglobin (HbA1c) <7% at the End of the Comparative Period